E-Pharmacy Market Report 2026

The e-pharmacy market size has grown exponentially in recent years. It will grow from $130.97 billion in 2025 to $161.08 billion in 2026 at a compound annual growth rate (CAGR) of 23%. The growth in the historic period can be attributed to growth in internet penetration, rising urban population, increasing burden of chronic diseases, expansion of smartphone usage, early adoption of online retail models.

The e-pharmacy market size is expected to see exponential growth in the next few years. It will grow to $367.69 billion in 2030 at a compound annual growth rate (CAGR) of 22.9%. The growth in the forecast period can be attributed to integration of AI in pharmacy operations, rising demand for doorstep healthcare services, increasing acceptance of digital payments, regulatory support for e-prescriptions, expansion of healthcare access in semi-urban and rural areas. Major trends in the forecast period include rapid growth of app-based e-pharmacy platforms, expansion of home delivery and same-day fulfillment models, rising adoption of e-prescriptions and digital refills, increasing demand for chronic disease medication subscriptions, growing consumer preference for contactless pharmacy services.

The rapid expansion of the digital health sector is expected to drive the growth of the healthcare IT and telemedicine markets in the coming years. Digital health includes technologies such as telemedicine platforms, mobile health applications, wearable devices, and online consultations that enhance access to care, patient engagement, and overall healthcare efficiency. The increasing adoption of digital health solutions is fueled by rising patient demand for convenient healthcare services, ongoing technological advancements, and supportive regulatory environments. For instance, in May 2024, according to Eurostat, a Luxembourg-based government agency, 8.5% of individuals in the European Union aged 16-74 engaged in online medical consultations in 2023. Therefore, the growing utilization of digital health technologies is significantly contributing to market growth.

Major companies operating in the e-pharmacy market are increasingly leveraging digital technologies to improve patient access to medications by offering services such as home delivery, telehealth consultations, and personalized medication management, thereby enhancing convenience and treatment adherence. LillyDirect is an innovative digital healthcare platform developed by Eli Lilly that provides personalized disease management tools, telehealth services, and direct-to-home medication delivery, particularly for patients with chronic conditions such as obesity, migraine, and diabetes. For example, in January 2024, Eli Lilly and Company, a US-based pharmaceutical company, launched LillyDirect in the United States to simplify healthcare access for patients living with these conditions. The platform includes LillyDirect Pharmacy Solutions, which enables patients to order select Lilly medications online for home delivery through partnered online pharmacy fulfillment services.

In November 2023, M1 Kliniken AG, a Germany-based provider of aesthetic and cosmetic medical services, acquired Direct Apotheke Venlo B.V. for an undisclosed amount. Through this acquisition, M1 Kliniken aims to strengthen its digital distribution infrastructure, secure long-term procurement benefits, and broaden its healthcare and pharmaceutical offerings. Direct Apotheke Venlo B.V. is a Netherlands-based online pharmacy company.

Major companies operating in the e-pharmacy market are Walgreen Company, Express Scripts Holding Company, CVS Health Corporation, DocMorris N. V, OptumRx Holdings LLC, PharmEasy, Tata 1mg, Netmeds, Amazon Inc., Apollo Pharmacy Ltd., Rowlands Phamacy, The Kroger Co., Wal-Mart Stores Inc., Medlife International Private Limited, MedPlus Health Services Private Limited, Medikabazaar Private Limited, MedPlusMart Private Limited, MedsIndia Limited, MedsOnCall Healthcare Private Limited, MedsSure Healthcare Private Limited, MedsDelight Healthcare Private Limited, MedsBazaar Healthcare Private Limited.

North America was the largest region in the e-pharmacy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the e-pharmacy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the e-pharmacy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the e-pharmacy market by increasing procurement costs for imported pharmaceutical products, packaging materials, and digital infrastructure hardware, thereby impacting pricing and margins. Prescription drugs, specialty medications, and technology-enabled app-based platforms are most affected, particularly in regions dependent on cross-border pharmaceutical trade such as Asia-Pacific and parts of Latin America. However, tariffs are also encouraging local drug sourcing, domestic manufacturing, and regional distribution partnerships, which may strengthen supply chain resilience and support long-term market sustainability.

The e-pharmacy market research report is one of a series of new reports that provides e-pharmacy market statistics, including e-pharmacy industry global market size, regional shares, competitors with a e-pharmacy market share, detailed e-pharmacy market segments, market trends and opportunities, and any further data you may need to thrive in the e-pharmacy industry. This e-pharmacy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

E-pharmacy refers to a business model that functions in a manner similar to conventional pharmacies by preparing and selling prescription and over-the-counter medicines. However, internet pharmacies enable customers to place orders online and have medications delivered directly to them. E-pharmacies allow patients to conveniently refill prescriptions and purchase over-the-counter as well as specialized medications.

The primary drug categories in e-pharmacy include prescription medicines and over-the-counter (OTC) drugs. Prescription medicines are utilized for the diagnosis, treatment, mitigation, cure, or prevention of diseases and can only be used under the guidance of a licensed medical professional. The various product categories offered include skin care, dental products, cold and flu remedies, vitamins, weight loss products, and others. Payment options typically include cash on delivery and online payment methods, and services are provided through multiple platforms such as app-based and web-based systems.

The E-pharmacy market includes revenues earned by entities by taking orders online and sending the drugs to their destination by post. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.